Prot# CEPO906A2212: An Open-Label, Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 (Epothilone B) as Therapy in Patients with Metastatic Carcinoid Tumors

Project: Research project

StatusFinished
Effective start/end date4/1/023/3/10

Funding

  • Novartis Pharmaceuticals Corporation (CEPO906A2212)